Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma

Autor: Walewski, Jan, Paszkiewicz-Kozik, Ewa *, Warszewska, Agnieszka *, Borsaru, Gabriela *, Moicean, Andreea *, Hellmann, Andrzej *, Mayer, Jiri, Hauns, Bernhard *, Mais, Anna *, Henning, Stefan W. *, Hentsch, Bernd *
Zdroj: In Blood 18 November 2011 118(21):2675-2675
Databáze: ScienceDirect